P2.209 Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease - Raisman Vozari, R.; Aguiar, A.; Rojas-Mayorquin, A.; Figueiredo, C.; Matheus, F.; Ginestet, L.; Chevarin, C.; DelBel, E.; Mongeau, R.; Hamon, M.; Lanfumey, L.; Prediger, R. (Parkinsonism & Related Disorders, 2009)